Though still in its infancy, research into salivary GFAP, an astrocytic biomarker associated with neuroinflammation in AD, is promising, correlating with the increasing roles of glial cells and microglia in AD pathophysiology.64 This evidence concerns the gene GFAP and Alzheimer disease.